OpenURL Connection Search

Select item for more details and to access through your institution.

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.
Published in:
Cancers, 2023, v. 15, n. 11, p. 2993, doi. 10.3390/cancers15112993
By:
- Mauro, Francesca R.;
- Giannarelli, Diana;
- Galluzzo, Clementina M.;
- Visentin, Andrea;
- Frustaci, Anna M.;
- Sportoletti, Paolo;
- Vitale, Candida;
- Reda, Gianluigi;
- Gentile, Massimo;
- Levato, Luciano;
- Murru, Roberta;
- Armiento, Daniele;
- Molinari, Maria C.;
- Proietti, Giulia;
- Pepe, Sara;
- De Falco, Filomena;
- Mattiello, Veronica;
- Barabino, Luca;
- Amici, Roberta;
- Coscia, Marta
Publication type:
Article
Intrahospital COVID‐19 infection outbreak management: Keep calm and carry on.
Published in:
Hematological Oncology, 2021, v. 39, n. 3, p. 431, doi. 10.1002/hon.2873
By:
- Frustaci, Anna M.;
- Pioltelli, Maria L.;
- Ravano, Emanuele;
- Di Ruscio, Federica;
- Campisi, Daniela A.;
- Puoti, Massimo;
- Cairoli, Roberto
Publication type:
Article
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies.
Published in:
American Journal of Hematology, 2020, v. 95, n. 12, p. 1473, doi. 10.1002/ajh.25961
By:
- Varettoni, Marzia;
- Ferrari, Angela;
- Frustaci, Anna M.;
- Ferretti, Virginia V.;
- Rizzi, Rita;
- Motta, Marina;
- Piazza, Francesco;
- Merli, Michele;
- Benevolo, Giulia;
- Visco, Carlo;
- Laurenti, Luca;
- Ferrero, Simone;
- Gentile, Massimo;
- Del Fabro, Vittorio;
- Abbadessa, Antonio;
- Klersy, Catherine;
- Musto, Pellegrino;
- Fabbri, Nicole;
- Deodato, Marina;
- Dogliotti, Irene
Publication type:
Article

Found: 3

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.

Intrahospital COVID‐19 infection outbreak management: Keep calm and carry on.

Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies.